[1]
O. Koliada, M. Myroshnychenko, N. Vdovichenko, and S. Krestetska, “Marker of intrathecal immune activation for the evaluation of the IFN-β efficacy in relapsing-remitting multiple sclerosis”, AMI, no. 4, pp. 27–31, Dec. 2021.